Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PfizerfiledCriticalPfizer
Publication of CL2017000242A1publicationCriticalpatent/CL2017000242A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
<p>LA PRESENTE INVENCIÓN ESTÁ DIRIGIDA A COMPUESTOS DE FÓRMULA I:</p> <p>* incluir figura de estructura hoja resumen , hoja 4 escrito 30-001-2017</p> <p>O UNA SAL FARMACÉUTICAMENTE ACEPTABLE DE LOS MISMOS, EN DONDE LOS SUSTITUTOS RI, R3, R6, R7 Y B SON COMO SE DEFINE EN LA PRESENTE. LA INVENCIÓN TAMBIÉN ESTÁ DIRIGIDA A COMPOSICIONES FARMACÉUTICAS QUE COMPRENDEN LOS COMPUESTOS, MÉTODOS DO TRATAMIENTO USANDO LOS COMPUESTOS Y MÉTODOS DE PREPARAR LOS COMPUESTOS.</p><p> THIS INVENTION IS DIRECTED TO FORMULA COMPOUNDS I: </p> <p> * include structure figure summary sheet, sheet 4 written 30-001-2017 </p> <p> OR A PHARMACEUTICALLY ACCEPTABLE SALT OF THE SAME, WHERE THE RI, R3, R6, R7 AND B SUBSTITUTES ARE AS DEFINED HEREIN. THE INVENTION IS ALSO ADDRESSED TO PHARMACEUTICAL COMPOSITIONS THAT INCLUDE COMPOUNDS, TREATMENT METHODS USING THE COMPOUNDS AND METHODS OF PREPARING THE COMPOUNDS. </p>